[ad_1] Three months after the second dose (administered 28 days after the first), participants in Moderna’s covid-19 vaccine study demonstrated high levels of antibodies. “This suggests that the vaccine will provide lasting immunity,” the lead researcher said. A new study recently published in The New England Journal of Medicine suggests …
Read More »Brazilian President Jair Bolsonaro says: “Don’t blame the consequences of the vaccine”
[ad_1] Brazilian President Jair Bolsonaro says: “Don’t blame the consequences of the vaccine” – YouTube Press InformationCopyrightContact UsContent CreatorsAd DevelopersTermsPrivacyPolicy & SecurityHow YouTube Works Try New Features © 2020 Google LLC . [ad_2] Source link
Read More »IBM denounces “high-precision” cyber attacks on vaccine distribution
[ad_1] JN / Agencies Yesterday at 11:51 pm IBM has detected a campaign of “high-precision” cyberattacks against the cold chain that will help facilitate the distribution of vaccines against covid-19. The series of attacks, detected by an investigation by the cybercrime department of that American technology company, began in September …
Read More »A participant in clinical trials for the COVID vaccine describes the side effects. “It doesn’t last long. It’s worse if you don’t get vaccinated.”
[ad_1] Yasir Batalvi, a young participant in clinical trials for the COVID-19 vaccine developed by the pharmaceutical company Moderna, spoke in an interview on CNN about the side effects he experienced after being vaccinated. “30 minutes after receiving the vaccine, I felt pain and numbness in my arm. As if …
Read More »Coronavirus: WHO holds Q&A on social media in response to questions about Covid-19 pandemic – watch live
[ad_1] Coronavirus: WHO holds questions and answers on social media answering questions about Covid-19 pandemic – watch live – YouTube Press InformationCopyrightContact UsContent CreatorsAd DevelopersTermsPrivacyPolicy & SecurityHow YouTube Works Try New Features © 2020 Google LLC . [ad_2] Source link
Read More »Moderna vaccine is ready and waiting to be authorized by the European Medicines Agency
[ad_1] The American company Moderna announced that the full results of the latest clinical study confirmed a 94.1% efficacy of its COVID-19 vaccine and will require emergency clearance from both the Food and Drug Administration (FDA) in The United States, as well as the European Medicines Agency (EMA), inform Agepres. …
Read More »Could a new mutation in the SARS-CoV-2 virus reduce the effectiveness of vaccines?
[ad_1] Health 14:31 28.11.2020(updated 15:28 28.11.2020) Short URL https://cdnfr1.img.sputniknews.com/img/07e4/0b/1c/1044846648_0:-1:1920:1080_1200x675_80_0_0_5502392f9e4a881a267cbb71bd2c266f.jpg Sputnik France https://cdnfr2.img.sputniknews.com/i/logo.png Youlia Zvantsova. Sputnik France https://fr.sputniknews.com/sante/202011281044846685-une-nouvelle-mutation-du-virus-sras-cov-2-pourrait-elle-reduire-lefficacite-des-vaccins/ Scientists are working hard to develop an effective Covid-19 vaccine, but a recently discovered mutant strain could dampen the effectiveness of some. As the world grapples with developing a vaccine for Covid-19, some …
Read More »Russians propose to combine Sputnik vaccine with COVID with AstraZeneca for greater efficiency
[ad_1] Russian developers of the COVID-19 vaccine, Sputnik V, said AstraZeneca should combine its vaccine with the Russian one in order to increase its efficiency, Reuters informs. Russia announced that the Sputnik vaccine is 92% effective in protecting against COVID-19, according to preliminary data, while the vaccine developed by AstraZeneca …
Read More »The manufacturing error raises doubts about testing with the AstraZeneca / Oxford vaccine
[ad_1] JN / Agencies Today at 00:03 AstraZeneca and the University of Oxford today acknowledged a manufacturing error that raises questions about the preliminary results and efficacy of their experimental covid-19 vaccine. The claim, where the mistake is acknowledged, comes days after the company and university called the vaccine “highly …
Read More »Half the dose was given to young people
[ad_1] The lower dose of COVID vaccine, 90% effective during clinical trials conducted by Oxford and AstraZeneca, was given to younger subjects than the higher dose, which showed lower efficacy, says Operation Warp Speed chief. Moncef Slaoui, quoted by Bloomberg. The vaccine developed with the University of Oxford has been …
Read More »